Author:
Ahmad Sharique,Kumar Raushan
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. . Gaziano T, Reddy KS, Paccaud F, Horton S, Chaturvedi V (2006) Cardiovascular Disease. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., (eds) Disease control priorities in developing countries, 2nd ed. The International Bank for Reconstruction and Development/The World Bank, Washington. http://www.ncbi.nlm.nih.gov/books/NBK11767/
2. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS et al (2022) Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation. https://doi.org/10.1161/CIR.0000000000001052
3. Hossain ME, Uddin S, Khan A, Moni MA (2020) A framework to understand the progression of cardiovascular disease for type 2 diabetes mellitus patients using a network approach. Int J Environ Res Public Health 17(2):596
4. Omran F, Kyrou I, Osman F, Lim VG, Randeva HS, Chatha K (2022) Cardiovascular biomarkers: lessons of the past and prospects for the future. IJMS. 23(10):5680
5. Stern CS, Lebowitz J (2010) Latest drug developments in the field of cardiovascular disease. Int J Angiol 19(3):e100-105
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献